M. Omi et al., INTERLEUKIN (IL)-6 AS A PANCREAS CARCINOMA-DERIVED VASCULAR-PERMEABILITY REGULATOR IN-VITRO, Pathology research and practice, 192(11), 1996, pp. 1107-1112
The interaction between pancreas adenocarcinoma and vascular endotheli
al cells in vitro was investigated. Culture media of pancreas carcinom
a cells PCI-10, but not PCI-24, induced an augmented albumin permeabil
ity across the endothelial monolayer, an event which was blocked by th
e calmodulin antagonist, W-7. Only marginal inhibitory effects were ob
tained using protein kinase inhibitors, H-7 and HA-1004. When cytokine
production by pancreas carcinoma cells was examined, production of IL
-6 in large amounts by PCI-10, but not by PCI-24 cells was evident. As
recombinant IL-6 generated a dose-dependent permeability increase, an
d as this effect was inhibited by W-7, we considered that the enhancem
ent of vascular permeability was mediated by this cytokine. The activi
ty of culture supernatants for enhanced permeability was almost comple
tely absorbed by the addition of an antibody specific for IL-6. Tumor-
derived IL-6 as a soluble mediator regulates vascular permeability in
vitro, and the production of this factor by pancreas adenocarcinoma ce
lls presumably modulates biologic behavior.